Have mood disorders any influence over seizure control in patients with epilepsy?

Jacoby, 1996, The clinical course of epilepsy and its psychosocial correlates: findings from a U.K. Community Study, Epilepsia., 37, 148, 10.1111/j.1528-1157.1996.tb00006.x Ettinger, 2004, Depression and comorbidityin community-based patients with epilepsy or asthma, Neurology., 63, 1008, 10.1212/01.WNL.0000138430.11829.61 Gaitatzis, 2012, The somatic comorbidity of epilepsy: a weighty but oftenunrecognized burden, Epilepsia., 53, 1282, 10.1111/j.1528-1167.2012.03528.x Kanner, 2016, Management of psychiatric and neurological comorbidities in epilepsy, Nat Rev Neurol., 12, 106, 10.1038/nrneurol.2015.243 Hesdorffer, 2012, Epilepsy, suicidality, and psychiatric disorders: a bidirectional association, Ann Neurol., 72, 184, 10.1002/ana.23601 Josephson, 2017, Association of depression and reated depression with epilepsy and seizure outcomes: a multicohort analysis, JAMA Neurol., 74, 533, 10.1001/jamaneurol.2016.5042 Kanner, 2006, Depression and epilepsy: a new perspective on two closely related disorders, Epilepsy Curr., 6, 141, 10.1111/j.1535-7511.2006.00125.x Kanner, 2012, Depressive and anxiety disorders inepilepsy: do they differ in their potential to worsen common antiepileptic drug-relatedadverse events?, Epilepsia., 53, 1104, 10.1111/j.1528-1167.2012.03488.x Hitiris, 2007, Predictors of pharmacoresistant epilepsy, Epilepsy Res., 75, 192, 10.1016/j.eplepsyres.2007.06.003 Tedrus, 2019, Resilience, quality of life, and clinical aspects of patients with epilepsy, Epilepsy Behav., 24, 106398 Maguire, 2014, Antidepressants for people with epilepsy and depression, Cochrane Database Syst Rev., CD010682 Cramer, 1996, A brief questionnaire to screen for quality of life in epilepsy: the QOLIE-10, Epilepsia, 37, 577, 10.1111/j.1528-1157.1996.tb00612.x Viteri, 2008, grupo de investigadores del estudio de validación del cuestionario QOLIE-10. [Validation of the Spanish version of the QOLIE-10 quality of life in epilepsy questionnaire], Neurologia, 23, 157 Gilliam, 2006, Rapid detection of majordepression in epilepsy: a multicentre study, Lancet Neurol., 5, 399, 10.1016/S1474-4422(06)70415-X di Capua Sacoto DR. Validación al castellano del «Inventario de depresión en trastornos neurológicos en paciente con epilepsia», un instrumento para la detección de depresión mayor en pacientes con epilepsia [tesis]; 2014. Directores de la Tesis: García Morales I, Matias-Guiu Guia J. Madrid: Universidad Complutense de Madrid; 2015. Spitzer, 2006, A brief measure for assessing generalized anxiety disorder: the GAD-7, Arch Internal Med., 166, 1092, 10.1001/archinte.166.10.1092 Park, 2017, Seizure control and memory impairment are related to disrupted brain functional integration in temporal lobe epilepsy, J Neuropsychiatry Clin Neurosci., 29, 343, 10.1176/appi.neuropsych.16100216 Gelenberg, 2010, The prevalence and impact of depression, J Clin Psychiatry., 71, e06, 10.4088/JCP.8001tx17c Kanner, 2003, Depression in epilepsy: a frequently neglected multifaceted disorder, Epilepsy Behav., 4, 11, 10.1016/j.yebeh.2003.10.004 Boylan, 2004, Depression but not seizurefrequency predicts quality of life in treatment-resistant epilepsy, Neurology., 62, 258, 10.1212/01.WNL.0000103282.62353.85 De Oliveira, 2010, Brazilianversion of the Neurological Disorders Depression Inventory for Epilepsy (NDDI-E), Epilepsy Behav., 19, 328, 10.1016/j.yebeh.2010.07.013 Hovorka, 2000, Treatment of interictal depression with citalopram in patients with epilepsy, Epilepsy Behav., 1, 444, 10.1006/ebeh.2000.0123 Kanner, 2000, The use of sertraline in patients with epilepsy: is it safe?, Epilepsy Behav., 1, 100, 10.1006/ebeh.2000.0050 Thomé-Souza, 2007, Sertraline and fluoxetine: safe treatments for children and adolescents with epilepsy and depression, Epilepsy Behav., 10, 417, 10.1016/j.yebeh.2007.01.004 Favale, 2003, The anticonvulsant effect of citalopram as an indirectevidence of serotonergic impairment in human epileptogenesis, Seizure., 12, 316, 10.1016/S1059-1311(02)00315-1 Alper, 2007, Seizure incidence in psychopharmacological clinicaltrials: an analysis of Food and Drug Administration (FDA) summary basis of approval reports, Biol Psychiatry., 62, 345, 10.1016/j.biopsych.2006.09.023 Kanner, 2002, Depression and epilepsy: how closely related are they?, Neurology., 58, S27, 10.1212/WNL.58.8_suppl_5.S27 Hesdorffer, 2000, Major depression is a risk factor for seizuresin older adults, Ann Neurol., 47, 246, 10.1002/1531-8249(200002)47:2<246::AID-ANA17>3.0.CO;2-E Kanner, 2003, Depression in epilepsy: prevalence, clinical semiology, pathogenic mechanisms, and treatment, Biol Psychiatry., 54, 388, 10.1016/S0006-3223(03)00469-4 Kwon, 2011, What is the role of depressive symptoms among other predictors of quality oflife in people with well-controlled epilepsy on monotherapy?, Epilepsy Behav., 20, 528, 10.1016/j.yebeh.2011.01.010